Rapport Therapeutics, Inc.(RAPP) - 2025 Q4 - Annual Results

Exhibit 99.1 Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update BOSTON and SAN DIEGO, March 10, 2026 -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) ("Rapport" or the "Company"), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological and psychiatric disorders, today reported financial results for the quarter and full year ended December 31, 2025, and provide ...